Andrea Acosta - Apr 30, 2021 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
GVP, Chief Accounting Officer
Signature
/s/ Eric Fleekop, Attorney-in-Fact
Stock symbol
BMRN
Transactions as of
Apr 30, 2021
Transactions value $
-$5,557
Form type
4
Date filed
7/19/2021, 08:55 PM
Next filing
Feb 17, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Award $16.9K +271 +1.49% $62.41 18.4K Apr 30, 2021 Direct F1
transaction BMRN Common Stock Tax liability -$22.5K -285 -1.55% $78.84 18.1K Jul 16, 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares acquired by the reporting person on April 30, 2021, pursuant to the issuer's Employee Stock Purchase Plan.